Emcure will play a crucial role in ensuring the availability of high-quality, low-cost versions of lenacapavir in 120 countries
The Lilly Medicine Foundry is set to drive innovation in drug production and make medicines for clinical trials
This facility underwent an inspection from 15th to 19th July 2024 and has been classified as Voluntary Action Indicated
Gilead Sciences first launched Lenacapavir under the brand name Sunlenca in the United States and Europe markets in the year 2022
Showcases specialty and sustainable materials for healthcare at Medtec China 2024
The product is an additional formulation of Cresemba Capsule 100 mg and Cresemba Intravenous Infusion 200 mg
Wacker Biotech will manufacture the active ingredients of MinervaX’s novel vaccine candidate
The USFDA inspection focused on evaluating the facility's adherence to global regulatory requirements and best practices
Increases efficiency by 70% compared to stainless steel or glass manufacturing methods
Jubilant HollisterStier is a subsidiary of Jubilant Pharma Holding
Subscribe To Our Newsletter & Stay Updated
